This Week in Congress- February 5, 2021 |NCSD This Week in Congress- February 5, 2021 - NCSD
Skip to main content

NCSD

  • Search
  • Contact
  • STD Information & Resources
  • About
    • Acknowledgements & Partners
    • Board of Directors
    • Our Staff
    • NCSD Full Members
  • Our Work
    • NCSD Projects
    • Health Equity
    • Partnerships & Collaborations
    • Federal & State Policy
    • Clinic+: The STD and Sexual Health Clinic Initiative
    • Disease Intervention Specialists (DIS)
    • Technical Assistance
  • Get Involved
    • NCSD Membership
    • Job Board
    • NCSD Member Login
    • Explore Resources
    • Share Your Story
    • Take Action
  • Resources
  • Events
  • News & Announcements
> News & Announcements > This Week in Congress- February 5, 2021
Policy Update

This Week in Congress- February 5, 2021

Here's the scoop on what's happening this week in Congress

Author
NCSD Policy Staff
Release Date
February 5, 2021

COVID Relief

On Monday, President Biden met with a group of Republican senators who shared a counterplan to his proposed $1.9 trillion COVID rescue package. The Republican plan, totaling $618 billion, diverged significantly from the Biden plan – dedicating $220 billion for $1,000 direct payments to households, $160 billion for a national vaccine program, $40 billion for the Paycheck Protection Program (PPP), and $130 billion for state unemployment insurance $300/week boosts. Despite the differences, Sen. Susan Collins – speaking for her Republican colleagues – expressed positive sentiments surrounding the bipartisan conversation with the administration while still highlighting that no formal bipartisan agreement had been reached.

However, after weeks of cumbersome negotiation, Sen. Majority Leader Chuck Schumer and Minority Leader Mitch McConnell reached a power-sharing agreement, Wednesday, for governing the 50-50 split in the Senate. The organizing resolution, now permitting Democrats to take control of Senate committees, was approved by unanimous consent.

House Republicans voted by secret ballot on Wednesday evening (145-61) in favor of keeping Conference Chairwoman Liz Cheney in leadership. The vote is part of what has been deemed a “civil war” within the Republican Party after Rep. Cheney, alongside 9 other Republican colleagues, voted in favor of impeaching former President Donald Trump. The House convened on Thursday to vote in favor of a resolution (H Res 72) that removed Rep. Marjorie Taylor Green from her committee assignments.

The House and Senate also passed budget resolutions that give instructions to authorizing committees to draft a reconciliation bill that will contain the language to be included in the COVID-19 package. Fifteen hours and 14 roll call votes later, at 5:30 am Friday, the Senate voted 51-50 to adopt a budget resolution for the administration’s $1.9 trillion virus relief package. House and Senate committees (like the House Energy and Commerce Committee responsible for drafting relevant health proposals that will be included in the package) will have until February 16th to write the stimulus legislation. Democrats hope to pass the COVID relief legislation by March 14 – the day that current enhanced unemployment benefits expire.

COVID-19 PuLSE

Last Friday, the CDC issued an order that went into effect Monday night at 11:00 pm mandating all people using public transportation to wear a face covering. Now – a week after the order –  the U.S. has surpassed 440,000 coronavirus-related deaths and a reported average of 117,000 people diagnosed each of the past 7 days. Despite the statistics, new cases, hospitalizations, and death averages dropped significantly this week. Currently, 35 million vaccination doses have been administered – constituting 8.5% of the population given at least 1 shot and 2.1% of the population given 2 shots. So far, the U.S. has administered an average of 1.3 million shots per day.

Johnson & Johnson applied for FDA emergency use authorization on Thursday following news of their newly developed one-shot vaccination which — based on an international trial of 44,000 volunteers – is 72% effective in the U.S. and 85% effective globally. The news comes as Pfizer announced its expectation to sell $15 billion worth of their new vaccine.

Read this next:

Policy Update

This Week in Congress – April 9, 2021

April 9, 2021
Policy Update

HIV Community Funding Requests for FY2022 Domestic HIV Programs

April 2, 2021
Policy Update

This Week in Congress – April 2, 2021

April 2, 2021
Become an NCSD Member! Learn more here.
NCSD
  • About
    • Our Staff
    • Board of Directors
    • Acknowledgements & Partners
    • NCSD Full Members
  • Our Work
    • Member Services
    • NCSD Projects
    • Health Equity
    • Federal & State Policy
    • Technical Assistance
    • Partnerships & Collaborations
    • DIS
    • Clinic+: The STD and Sexual Health Clinic Initiative
  • Get Involved
    • Become a member
    • Find a Job
    • Explore Resources
    • Share Your Story
    • Take Action
  • Resources
  • News & Announcements
  • Events
  • Get in Touch
  • Organizational Financial Statements
© CopyrightNCSD2021.
Privacy Policy Credits
Follow by Email
Facebook
Share
Twitter
Follow
SHARE
LINKEDIN